Loading news...
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Amgen Inc. (AMGN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
High-yield stocks are outperforming, with a clear rotation from growth to value driving strong returns for dividend-focused investors. Safe, high-yielding companies are still trading at discounts. These 3 are in the process of rerating, providing an appealing position to initiate a position.
111 Capital acquired a new position in shares of Amgen Inc. (NASDAQ: AMGN) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 6,843 shares of the medical research company's stock, valued at approximately $1,931,000. A number of
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.7% yield and -10% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DNB Asset Management AS reduced its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 10.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 139,527 shares of the medical research company's stock after selling 16,121 shares during
If you have $10,000 that you won't need to spend anytime soon, there are ways to derive passive income from that money.
Bradley Foster and Sargent Inc. CT reduced its position in shares of Amgen Inc. (NASDAQ: AMGN) by 8.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 14,414 shares of the medical research company's stock after selling 1,336 shares during the quarter.
THOUSAND OAKS, Calif., Feb. 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 46th Annual TD Cowen Health Care Conference at 1:10 p.m.
Dakota Wealth Management trimmed its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 25.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,414 shares of the medical research company's stock after selling 11,003 shares during the period. Dakota Wealth Management's
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pre-Market Stock Futures: Futures are trading lower as we wrap up the holiday-shortened week that gave us a little taste of just about everything. While Walmart posted results that beat expectations, its forward guidance and outlook fell short of Wall Street's expectations, and the stock was down from the opening bell to the close. All... Here Are Friday's Top Wall Street Analyst Research Calls: Amgen, ETSY, Eldorado Gold, GE Aerospace, Merck, Southern Company, Walmart, Yeti, and More.
China Universal Asset Management Co. Ltd. raised its holdings in Amgen Inc. (NASDAQ: AMGN) by 7.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 64,628 shares of the medical research company's stock after buying an additional 4,201 shares during the quarter. Amgen
Amgen Inc. (AMGN) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
Assetmark Inc. boosted its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 5.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 213,793 shares of the medical research company's stock after acquiring an additional 10,886 shares during the quarter. Assetmark Inc.'s
Guru Stock PicksRobert Bruce has made the following transactions:Reduce in NEE by 1.49%Ray Dalio has made the following transactions:Reduce in CNX by 13.43%Sold
/PRNewswire/ -- Amgen (NASDAQ: AMGN) gab heute bekannt, dass die Europäische Kommission (EC) UPLIZNA (Inebilizumab) als Zusatzbehandlung zur Standardtherapie
THOUSAND OAKS, Calif., Feb. 13, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2026 Virtual Oncology Leadership Summit at 12:15 p.m.